Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
06/25/2002 | US6410533 Therapy for bacteria infections |
06/25/2002 | US6410301 Genetically engineered cells; for use in generating carcinogenic agents |
06/25/2002 | CA2220024C Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents |
06/20/2002 | WO2002048150A2 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
06/20/2002 | WO2002048140A1 5-[(pyrazol-4-yl)carbonyl]benzazolone as herbicide |
06/20/2002 | WO2002048124A2 Piperazine derivatives |
06/20/2002 | WO2002048121A1 Benzazolonylcarbonyl cyclohexenones and use thereof as herbicides |
06/20/2002 | WO2002048106A2 Isoindolin-1-one glucokinase activators |
06/20/2002 | WO2002047762A1 Serine protease inhibitors |
06/20/2002 | WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
06/20/2002 | US20020077483 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction |
06/20/2002 | US20020077455 Protease inhibitors |
06/20/2002 | US20020077343 H2 receptor antagonist compounds in combination with nitric oxide donors, compostions and methods of use |
06/20/2002 | CA2431268A1 5-[(pyrazol-4-yl)carbonyl]benzazolone as herbicide |
06/20/2002 | CA2431267A1 Benzazolonylcarbonyl cyclohexenones and use thereof as herbicides |
06/20/2002 | CA2365374A1 Condensation reagents and a process for their preparation |
06/19/2002 | EP1215208A2 4-Aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
06/19/2002 | EP1215207A2 Salts of isoleucyl-thiazolidine and -pyrrolidine and their use as dipeptidylpeptidase inhibitors |
06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
06/19/2002 | EP1214936A2 Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents |
06/19/2002 | EP1214317A1 Antiviral agents |
06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
06/19/2002 | EP1214303A1 Heterocyclic compounds and methods of use thereof |
06/19/2002 | EP1214292A1 Tyrosine derivatives |
06/19/2002 | CN1354740A Pharmaceutical compounds |
06/19/2002 | CN1354661A Novel method of treatment |
06/19/2002 | CN1086388C Process for preparation of thiazole derivs. |
06/18/2002 | US6407252 Reacting valine with bistrichloromethyl carbonate; cyclization |
06/18/2002 | US6407251 Reacting 2-halogeno-allyl isothiocyanate with chlorination agent in presence of aromatic hydrocarbon |
06/18/2002 | US6407248 α-unsaturated amines, their production and use |
06/18/2002 | US6407230 Method for producing lactams using oligophosphate catalysts |
06/18/2002 | US6407124 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
06/13/2002 | WO2002046176A1 Ppar (peroxisome proliferator activated receptor) activators |
06/13/2002 | WO2002046175A1 Process for producing anhydride of aminothiazole derivative |
06/13/2002 | WO2002046173A1 Fused heteroaromatic glucokinase activators |
06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
06/13/2002 | WO2002016335A3 Catalytic process for the preparation of thiazole derivatives |
06/13/2002 | WO2001083438A3 New gamma selective retinoids |
06/13/2002 | US20020072528 Are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit T-helper-type 2 immune response; useful for therapy of viral and neoplastic diseases |
06/13/2002 | US20020072519 Useful as psychotherapeutic agents |
06/13/2002 | DE10061083A1 Bis-(2-chlor-thiazolyl-5-methyl)-amin und seine Salze sowie Verfahren zur Aufarbeitung von 5-Aminomethyl-2-chlor-thiazol und Bis-(2-chlor-thiazol-5-methyl)-amin enthaltenden Reaktionsgemischen Bis (2-chlorothiazolyl-5-methyl) amine and its salts and processes for the work-up of 5-aminomethyl-2-chloro-thiazole and bis- (2-chloro-thiazole-5-methyl) -amine-containing reaction mixtures |
06/13/2002 | CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
06/13/2002 | CA2430840A1 Process for producing anhydride of aminothiazole derivative |
06/12/2002 | EP1213287A1 Substituted benzylthiazolidine-2,4-dione derivatives |
06/12/2002 | EP1213286A1 Bis-(2-chlorothiazolyl-5-methyl)amine and process to produce 5-aminomethyl-2-chloro-thiazol |
06/12/2002 | EP1212619A1 Substrates and screening methods for transport proteins |
06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
06/12/2002 | EP0885210B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
06/12/2002 | CN1353690A Bradykinin receptor antagonists |
06/12/2002 | CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof |
06/12/2002 | CN1353109A Method of preparing dithiazole disulfide |
06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
06/11/2002 | US6403803 Removing ammonia from reaction mixture, mixing with water and inorganic acid to precipitate bis(2-chlorothiazolyl-5-methyl)amine salt, leaving 5-aminomethyl-2-chlorothiazole salt in solution, separating |
06/11/2002 | US6403624 8,8A-dihydroindeno[1,2-D] thiazole derivatives which are substituted in the 8A-position; processes for their preparation and their use as medicaments |
06/11/2002 | US6403622 For controlling insects, arachnids, nematodes |
06/11/2002 | US6403620 Inhibitors of factor Xa with a neutral P1 specificity group |
06/11/2002 | US6403612 Urea containing compounds inhibit the aggregation of blood platelets; nontoxic |
06/11/2002 | US6403592 Serotonin reuptake inhibitors |
06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
06/11/2002 | US6403572 Producing Z-isomer of hydrogen bromide salt of 2-aminothiazole derivative |
06/11/2002 | US6403532 Herbicidal synergistic composition, and method of controlling weeds |
06/11/2002 | US6403346 Enzymatic processes for producing intermediates useful in the manufacture of retiferol derivatives |
06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
06/06/2002 | WO2002014294A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
06/06/2002 | US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles |
06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
06/05/2002 | EP1003719B1 Microbicidal n-sulfonylglycin alkynyloxyphenemethyl amide derivatives |
06/05/2002 | EP0970090B1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
06/05/2002 | EP0790057B1 Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof |
06/05/2002 | EP0755386B1 Benzamide derivative, compositions containing said derivative and use thereof |
06/04/2002 | USRE37729 Useful as antipsychotic and analgesic agents. |
06/04/2002 | US6399783 Chemical intermediate for taxol |
06/04/2002 | US6399640 Arylthiazolidinedione and aryloxazolidinedione derivatives |
06/04/2002 | US6399638 Anticarcinogenic agents; microtubule stabilizing effects |
06/04/2002 | CA2067929C Piperazine derivatives |
05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
05/30/2002 | WO2002042283A1 Improved process for water soluble azole compounds |
05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
05/30/2002 | WO2002041892A1 Water-soluble liquid internal medicine |
05/30/2002 | WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
05/30/2002 | WO2002014275A3 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
05/30/2002 | WO2001060343A3 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers |
05/30/2002 | WO2001040223B1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
05/30/2002 | US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria |
05/30/2002 | US20020065283 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders |
05/30/2002 | US20020065278 Non-imidazole aryloxyalkylamines |
05/30/2002 | US20020065275 To increase insulin secretion, which makes them useful for treating type II diabetes |